tirzepatide for nash achieves high resolution in phase 2 trial GLP-2 (T) - Simon's Compounding

For longer breaks or if unsure, always call your doctor before restarting or changing your dose

The typical escalation looks like this: Weeks 1 through 4: 0.25 mg per week (adjustment phase, minimal visible effects) Weeks 5 through 8: 0.5 mg per week (appetite suppression becomes more consistent) Weeks 9 through 12: 1.0 mg per week (significant appetite reduction, weight loss accelerates) Weeks 13 through 16: 1.7 mg per week (strong effects for most users) Week 17 onward: 2.4 mg per week (full therapeutic dose) Each dose increase brings a noticeable step up in effect intensity

Full-Spectrum Wellness Our approach goes beyond the scale

EguchiYKitajimaYHyogoHTakahashiHKojimaMOnoMet al

See the safety section above for complete information